HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice.

Abstract
A single dose of the orexin-1 (OX1) receptor antagonist 1-(2-methylbenzoxazol-6-yl)-3-[1,5] naphthyridin-4-yl urea hydrochloride (SB-334867-A) reduces orexin-A-induced feeding and natural feeding in Sprague Dawley rats. In this study, the anti-obesity effects of SB-334867-A were determined in genetically obese (ob/ob) mice dosed with SB-334867-A (30 mg/kg, i.p.) once daily for 7 days, and then twice daily for a further 7 days. SB-334867-A reduced cumulative food intake and body weight gain over 14 days. Total fat mass gain, determined by Dual Emission X-ray Absorptiometry, was reduced, while gain in fat-free mass was unchanged. Fasting (5 h) blood glucose was also reduced at the end of the study, with a trend to reduced plasma insulin. Interscapular brown adipose tissue (BAT) weight was reduced, the tissue was noticeably darker in colour and quantitative PCR (TaqMan) analysis of this tissue showed a trend to an increase in uncoupling protein-1 mRNA expression, suggesting that SB-334867-A might stimulate thermogenesis. This was confirmed in a separate study in which a single dose of SB-334867-A (30 mg/kg, i.p.) increased metabolic rate over 4 h in ob/ob mice. OX1 receptor mRNA was detected in BAT, and its expression was increased by 58% by treatment with SB-334867-A. This is the first demonstration that OX1 receptor antagonists have potential as both anti-obesity and anti-diabetic agents.
AuthorsAndrea C Haynes, Helen Chapman, Colleen Taylor, Gary B T Moore, Michael A Cawthorne, Mohammad Tadayyon, John C Clapham, Jonathan R S Arch
JournalRegulatory peptides (Regul Pept) Vol. 104 Issue 1-3 Pg. 153-9 (Mar 15 2002) ISSN: 0167-0115 [Print] Netherlands
PMID11830290 (Publication Type: Journal Article)
Chemical References
  • 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea
  • Benzoxazoles
  • Insulin
  • Naphthyridines
  • Orexin Receptors
  • RNA, Messenger
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide
  • Urea
Topics
  • Adipose Tissue, Brown (drug effects)
  • Animals
  • Benzoxazoles (pharmacology)
  • Body Composition (drug effects)
  • Body Weight (drug effects)
  • Diabetes Mellitus, Type 2 (blood, drug therapy)
  • Disease Models, Animal
  • Eating (drug effects)
  • Energy Metabolism (drug effects)
  • Female
  • Insulin (blood)
  • Mice
  • Mice, Inbred Strains
  • Naphthyridines
  • Obesity (blood, genetics, physiopathology)
  • Orexin Receptors
  • RNA, Messenger (biosynthesis, drug effects)
  • Receptors, G-Protein-Coupled
  • Receptors, Neuropeptide (antagonists & inhibitors, biosynthesis, genetics, metabolism)
  • Urea (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: